Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Share on Pinterest From newly approved medications to promising research on the road to a potential cure, 2022 was a year filled with significant advancements in HIV care and prevention. Natalie ...
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ T-cells at 24 weeks of therapy predicted the subsequent reduction in the ...
Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...
A person with HIV may be more at risk of developing tuberculosis (TB). This is due to the weakening of the immune system that occurs in someone who has HIV. Tuberculosis (TB) is a bacterial infection ...
This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results